Business
Namaste Announces Health Canada Final Inspection, Appointment of New COO David Giardino and Filing of NCIB Shares
Namaste Announces Health Canada Final Inspection, Appointment of New COO David Giardino an...
About this update from Lifeist Wellness Inc
[{"type":"text","content":"\n\n\n\nNamaste Announces Health Canada Final Inspection, Appointment of New COO David Giardino and Filing of NCIB Shares\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, Aug. 13, 2018\n\n\n\nVANCOUVER, Aug. 13, 2018 /CNW/ - Namaste Technologies Inc. (\"Namaste\" or the \"Company\") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that the Company's wholly-owned subsidiary, Cannmart Inc. (\"Cannmart\"), a licensed cannabis producer under the Access to Cannabis for Medical Purposes Regulations (the \"ACMPR\"), has completed Health Canada's Pre-Sales License Inspection at the Cannmart facility in Etobicoke, Ontario. On July 31st, 2018, Health Canada inspectors were on-site to verify information submitted by Cannmart as part of its application and in assessing compliance with the applicable sections of the ACMPR prior to license approval. The Pre-Sales License Inspection is one of the last steps prior to the issuance of a Sales License under the ACMPR. \n\n\n \n \n\n \nCannmart's ACMPR \"sales-only\" license will be the first of its kind in Canada. The license enables Namaste to aggregate cannabis strains from licensed producers across the country, with the goal of offering medical patients access to the largest variety of medical cannabis products in a single platform. Namaste has positioned itself as a leader in the development of innovative cannabis e-commerce technology and will leverage its expertise and its platform powered by the Company's wholly-owned subsidiary and AI technology company, Findify AB (\"Findify\" or \"Findify.io\") to offer medical patients the most personalized user experience possible. \n\nIn anticipation of its upcoming ACMPR Sales License, Namaste is focused on accelerating patient acquisition through the launch of its updated version of the NamasteMD mobile app and by initiating several strategic marketing initiatives. NamasteMD is a telemedicine application which allows patients across Canada to access nurse practitioners or doctors for medical consultations via phone or video conference, free of ...